Huiyu Pharmaceuticals (688553.SH): Multiple products receive overseas listing approval.

15:41 19/11/2025

Huiyu Pharmaceutical (688553.SH) issued an announcement, the company's subsidiary Seacross Pharmac...

Huayu Pharmaceuticals (688553.SH) announced that its subsidiary, Seacross Pharmaceuticals Ltd., has recently received approval from the Pakistan Drug Regulatory Authority, the UK Medicines and Healthcare Products Regulatory Agency, and the North Macedonia Agency of Medicines and Medical Devices to market the company's products Plestazol Injection, Setapeptide Injection, Azathioprine Injection, Zoledronic Acid Concentrate for Infusion, and Zoledronic Acid Injection.

On November 19, CG Services (06098) spent 6.174 million Hong Kong dollars to repurchase 1 million shares.

Where will the next decade lead us? A look at PDD Holdings Inc. Sponsored ADR Class A (PDD.US) from the perspective of a shift towards social responsibility.

SUNWAH KINGSWAY (00188) generated unaudited revenue of approximately HK$9 million from financial intermediation business in the third quarter.

On November 19, CG Services (06098) spent 6.174 million Hong Kong dollars to repurchase 1 million shares.

Where will the next decade lead us? A look at PDD Holdings Inc. Sponsored ADR Class A (PDD.US) from the perspective of a shift towards social responsibility.

SUNWAH KINGSWAY (00188) generated unaudited revenue of approximately HK$9 million from financial intermediation business in the third quarter.